ProstaGene is a biotechnology start up company that is developing technology based on patents of the Founder, Dr. Richard G. Pestell. ProstaGene LLC integrates proprietary molecular diagnostics with novel therapeutic screening and commercial experience in order to develop novel treatments for cancer.